Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Ohtsu, H. Baba, Y. Sakata, Y. Mitachi, N. Horikoshi, K. Sugimachi, T. Taguchi, for group (2000)
Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinomaBritish Journal of Cancer, 83
Y. Yamada, D. Takahari, H. Matsumoto, H. Baba, Masato Nakamura, Kazuhiro Yoshida, M. Yoshida, S. Iwamoto, K. Shimada, Y. Komatsu, Y. Sasaki, T. Satoh, Keiichi Takahashi, H. Mishima, K. Muro, M. Watanabe, Y. Sakata, S. Morita, Y. Shimada, K. Sugihara (2013)
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.The Lancet. Oncology, 14 13
P. Thirion, S. Michiels, J. Pignon, M. Buyse, A. Braud, Robert Carlson, M. O’connell, P. Sargent, P. Piedbois (2004)
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 18
W. Koizumi, N. Boku, K. Yamaguchi, Y. Miyata, A. Sawaki, T. Kato, Y. Toh, I. Hyodo, T. Nishina, T. Furuhata, K. Miyashita, Y. Okada (2009)
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancerAnnals of Oncology, 21
E. Matsushima, K. Yoshida, R. Kitamura (1997)
Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry.Journal of chromatography. B, Biomedical sciences and applications, 691 1
K. Yamazaki, T. Yoshino, N. Boku, T. Kojima, Y. Onozawa, S. Hironaka, A. Fukutomi, H. Yasui, K. Taku (2008)
Phase I/II study of S-1/LV plus oxaliplatin (SOL) for untreated metastatic colorectal cancer: Preliminary report of the phase I partJournal of Clinical Oncology, 26
Yasuhide Yamada, Makoto Tahara, T. Miya, T. Satoh, K. Shirao, Yasuhiro Shimada, Atsushi Ohtsu, Y. Sasaki, Yusuke Tanigawara (2008)
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancerBritish Journal of Cancer, 98
H. Pinedo, G. Peters (1988)
Fluorouracil: biochemistry and pharmacology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 6 10
P. Piedbois (1992)
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 6
K. Shirao, Paulo Hoff, A. Ohtsu, P. Loehrer, I. Hyodo, S. Wadler, R. Wadleigh, Peter O'Dwyer, K. Muro, Y. Yamada, N. Boku, Fumio Nagashima, J. Abbruzzese (2004)
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 17
A. Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortés-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Bail, C. Louvet, D. Hendler, F. Braud, C. Wilson, F. Morvan, A. Bonetti (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 16
K. Shirao, A. Ohtsu, H. Takada, Y. Mitachi, K. Hirakawa, N. Horikoshi, T. Okamura, K. Hirata, S. Saitoh, H. Isomoto, A. Satoh (2004)
Phase II study of oral S‐1 for treatment of metastatic colorectal carcinomaCancer, 100
L. Saltz, S. Clarke, E. Díaz-Rubio, W. Scheithauer, A. Figer, R. Wong, S. Koski, M. Lichinitser, T.S. Yang, F. Rivera, F. Couture, F. Sirzén, J. Cassidy (2023)
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 41
K. Yamazaki, T. Nishina, Takeshi Kato, T. Yoshino, Y. Miyata, T. Esaki, T. Moriwaki, N. Boku, I. Hyodo (2014)
Final results of phase II study of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination therapy (SOL+BV; SOLA) in metastatic colorectal cancer (mCRC).Journal of Clinical Oncology, 32
S. McGuire (2016)
World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015.Advances in nutrition, 7 2
R. Goldberg, D. Sargent, R. Morton, C. Fuchs, R. Ramanathan, S. Williamson, B. Findlay, H. Pitot, S. Alberts (2004)
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 1
A. Ohtsu, H. Baba, Y. Sakata, Y. Mitachi, N. Horikoshi, K. Sugimachi, T. Taguchi (2000)
Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.British journal of cancer, 83 2
S. Giacchetti, B. Perpoint, R. Zidani, N. Bail, R. Faggiuolo, C. Focan, P. Chollet, J. Llory, Y. Létourneau, B. Coudert, F. Bertheaut-Cvitkovic, D. Larregain-Fournier, A. Rol, S. Walter, R. Adam, J. Misset, F. Lévi (2000)
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 1
K Yamazaki, T Yoshino, N Boku (2008)
Phase I/II study of S-1/LV plus oxaliplatin (SOL) for untreated metastatic colorectal cancer: preliminary report of the phase I partProc Am Soc Clin Oncol, 26
Y. Rustum, F. Trave, Zakrzewski Sf, N. Petrelli, L. Herrera, A. Mittelman, Arbuck Sg, P. Creaven (1987)
Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.NCI monographs : a publication of the National Cancer Institute, 5
Y. Hong, Y. Park, Ho Lim, Jeeyun Lee, Tae Kim, Kyu-pyo Kim, S. Kim, J. Baek, J. Kim, Keunsung Lee, I. Chung, Sang‐Hee Cho, K. Lee, S. Shin, H. Kang, D. Shin, Sook Jo, Jae Lee (2012)
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.The Lancet. Oncology, 13 11
M. Rothenberg, A. Oza, R. Bigelow, J. Berlin, J. Marshall, R. Ramanathan, L. Hart, Sunil Gupta, C. Garay, Brent Burger, N. bail, D. Haller (2003)
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 11
H. Matsuoka, H. Ueo, K. Sugimachi, T. Akiyoshi (1992)
Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response.Cancer investigation, 10 4
C. Giessen, Ruediger Laubender, L. Weikersthal, A. Schalhorn, D. Modest, S. Stintzing, M. Haas, U. Mansmann, V. Heinemann (2013)
Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trialCancer Science, 104
C. Tournigand, T. André, E. Achille, G. Lledo, M. Flesh, D. Mery-mignard, E. Quinaux, C. Couteau, M. Buyse, G. Ganem, B. Landi, P. Colin, C. Louvet, A. Gramont (2023)
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 41
SOL demonstrated promising efficacy and acceptable toxicity as first-line chemotherapy for mCRC. Further studies of SOL combined with molecular target agents are warranted.
Cancer Chemotherapy and Pharmacology – Springer Journals
Published: Mar 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.